← Back to directory

Giulio Caravagna

Researcher Next ID · RN-044189

Researcher · Biochemistry, Genetics and Molecular Biology

University of Trieste

Trieste, Argentina

Accepting doctoral researchersFunding unknown
Works count
245
Citation count
3,052
H-index
25
i10-index
58

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Cancer Genomics and Diagnostics
Epigenetics and DNA Methylation
Cancer Immunotherapy and Biomarkers
Gene Regulatory Network Analysis
Lung Cancer Treatments and Mutations

Publications

  • Long-term lineage commitment in haematopoietic stem cell gene therapy

    Nature · 2024 · 10.1038/s41586-024-08250-x

  • The genomic landscape of 2,023 colorectal cancers

    Nature · 2024 · 10.1038/s41586-024-07747-9

  • Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors

    Nature Genetics · 2023 · 10.1038/s41588-023-01313-1

  • Phenotypic plasticity and genetic control in colorectal cancer evolution

    Nature · 2022 · 10.1038/s41586-022-05311-x

  • The co-evolution of the genome and epigenome in colorectal cancer

    Nature · 2022 · 10.1038/s41586-022-05202-1

  • Signatures of TOP1 transcription-associated mutagenesis in cancer and germline

    Nature · 2022 · 10.1038/s41586-022-04403-y

  • Germline MBD4 deficiency causes a multi-tumor predisposition syndrome

    The American Journal of Human Genetics · 2022 · 10.1016/j.ajhg.2022.03.018

  • Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma

    Annals of Oncology · 2022 · 10.1016/j.annonc.2022.12.002

  • Chromatin Velocity reveals epigenetic dynamics by single-cell profiling of heterochromatin and euchromatin

    Nature Biotechnology · 2021 · 10.1038/s41587-021-01031-1

  • The MOBSTER R package for tumour subclonal deconvolution from bulk DNA whole-genome sequencing data

    BMC Bioinformatics · 2020 · 10.1186/s12859-020-03863-1

  • Exploiting evolutionary steering to induce collateral drug sensitivity in cancer

    Nature Communications · 2020 · 10.1038/s41467-020-15596-z

  • Subclonal reconstruction of tumors by using machine learning and population genetics

    Nature Genetics · 2020 · 10.1038/s41588-020-0675-5

  • Spatially constrained tumour growth affects the patterns of clonal selection and neutral drift in cancer genomic data

    PLoS Computational Biology · 2019 · 10.1371/journal.pcbi.1007243

  • Learning mutational graphs of individual tumour evolution from single-cell and multi-region sequencing data

    BMC Bioinformatics · 2019 · 10.1186/s12859-019-2795-4

  • Reply to ‘Neutral tumor evolution?’

    Nature Genetics · 2018 · 10.1038/s41588-018-0256-z

  • Evolutionary dynamics of residual disease in human glioblastoma

    Annals of Oncology · 2018 · 10.1093/annonc/mdy506

  • Detecting repeated cancer evolution from multi-region tumor sequencing data

    Nature Methods · 2018 · 10.1038/s41592-018-0108-x

  • Algorithmic methods to infer the evolutionary trajectories in cancer progression

    Proceedings of the National Academy of Sciences · 2016 · 10.1073/pnas.1520213113

  • TRONCO: an R package for the inference of cancer progression models from heterogeneous genomic data

    Bioinformatics · 2016 · 10.1093/bioinformatics/btw035

  • CAPRI: efficient inference of cancer progression models from cross-sectional data

    Bioinformatics · 2015 · 10.1093/bioinformatics/btv296

  • Inferring Tree Causal Models of Cancer Progression with Probability Raising

    PLoS ONE · 2014 · 10.1371/journal.pone.0108358

  • The Interplay of Intrinsic and Extrinsic Bounded Noises in Biomolecular Networks

    PLoS ONE · 2013 · 10.1371/journal.pone.0051174

  • Tumour suppression by immune system through stochastic oscillations

    Journal of Theoretical Biology · 2010 · 10.1016/j.jtbi.2010.05.013

  • The Calculus of Looping Sequences

    Lecture notes in computer science · 2008 · 10.1007/978-3-540-68894-5_11

Current projects

    No projects listed.